Related Experiment Video
Updated: Jun 3, 2026
07:40
Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
Published on: June 29, 2020
Veterinary Immunology Committee Toolkit Workshop 2010: progress and plans.
1Moredun Research Institute, Pentlands Science Park, Bush Loan, Edinburgh EH26 0PZ, Scotland, UK. gary.entrican@moredun.ac.uk
Veterinary Immunology and Immunopathology
|April 8, 2011
Summary
The 3rd Veterinary Immunology Committee (VIC) Toolkit Workshop focused on reagent development and provision for veterinary immunology research. Key projects and networking initiatives were discussed to improve communication and avoid duplicated efforts in reagent creation.
Area of Science:
- Veterinary Immunology
- Reagent Development
- Research Networking
Background:
- The 3rd Veterinary Immunology Committee (VIC) Toolkit Workshop convened at the 9th International Veterinary Immunology Symposium (IVIS) in Tokyo, Japan.
- The workshop aimed to advance reagent development, commercialization, and provision for the veterinary immunology research community.
Framework:
- Discussions centered on fostering open communication regarding reagent development progress and future strategies.
- Emphasis was placed on avoiding duplicated efforts and refining priorities for reagent development.
Implementation:
- Presentations highlighted major reagent development and networking projects: BBSRC/RERAD Immunological Toolbox (2004-2009), US Veterinary Immune Reagent Network (VIRN 2006-2010, renewed 2010-2014), and EU NADIR (2009-2013).
- The use of reagents in assay development, including multiplexing technologies, was explored for advancing basic research.
Implications:
- Identified mechanisms for enhanced information exchange, with VIC playing a central role, particularly through websites.
- The workshop facilitated collaboration and strategic planning to support the veterinary immunology research community.
Related Concept Videos
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:51Vaccinations
Overview
01:36Humoral Immune Responses
Overview